Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    12583942 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Effect of Symbicort ® on GR in Sputum in COPD
Condition: Chronic Obstructive Lung Disease
Intervention: Drug: Symbicort®, Formoterol, Budesonide
2 Completed Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Fluticasone 500mcg BD via accuhaler or identical placebo

Indicates status has not been verified in more than two years